Aimmune Therapeutics Inc buy klostergang
Start price
15.09.19
/
50%
€21.97
Target price
04.11.21
€51.00
Performance (%)
32.94%
End price
17.06.21
-
Summary
This prediction is currently being closed. The BUY prediction by klostergang for Aimmune Therapeutics Inc has seen massive gains of 32.94%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aimmune Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% | 53.202% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% | 91.095% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% | 63.933% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% | 64.840% |
Comments by klostergang for this prediction
In the thread Aimmune Therapeutics Inc diskutieren
Die FDA stimmte mit 8- 1 für die Wirksamkeit von Aimmune Therapeutics` Palforzia (AR101), das die Häufigkeit und den Schweregrad von allergischen Reaktionen auf Erdnüsse bei jungen Menschen im Alter von 4 - 17 Jahren verringert.
Kursziel geändert auf 51,0